Abstract
Background/Aim: Cancer stem cells (CSCs) have been suggested playing a crucial role in the tumorigenesis and tumor progression. Clinically, concurrent chemoradiotherapy (CCRT) after transurethral resection of the bladder is the widely accepted treatment option for high-grade bladder urothelial carcinoma (UC); however, a proportion of bladder UC patients still suffer from recurrence and metastasis. In the present study, we investigated the stemness properties of bladder UC cells with respect to various disease stages. The metastatic capability and epithelial–mesenchymal transition (EMT) of the parental cells and the CSC cells of bladder UC
| Original language | English |
|---|---|
| Pages (from-to) | 4957-4968 |
| Number of pages | 12 |
| Journal | Anticancer Research |
| Volume | 41 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Oct 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Bladder urothelial carcinoma
- Cancer stem cell
- Chemoradioresistance
- Concurrent chemoradiotherapy
- Epithelial–mesenchymal transition
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint
Dive into the research topics of 'Effects of concurrent chemoradiotherapy on the metastasis and the mesenchymal transition of bladder urothelial carcinoma cells'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS